FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W5555583> ?p ?o ?g. }

• W5555583 endingPage "847" @default.
• W5555583 startingPage "842" @default.
• W5555583 abstract "Hepatitis E virus (HEV) is the causative agent for enteric non-A, non-B hepatitis. Transmission is mainly via the fecal-oral route but the possibility of an additional parenteric transmission has been raised. Patients undergoing chronic hemodialysis (HD) have an increased risk of exposure to blood transmitted agents. Previous studies concerning prevalence of antibodies to HEV (anti-HEV) among HD patients gave conflicting results. The aim of the study presented here was to determine the prevalence of anti-HEV among HD patients of a well-defined semi-rural region in central Greece (Thessalia region). All patients (n=351, 234 males, mean age 60 ± 14 years) who were being treated in the HD units of central Greece (n=5) during 2001 were tested for anti-HEV antibody. Two commercially available specific solid-phase enzyme-linked immunoassays were applied for anti-HEV detection. Hepatitis B virus markers, antibodies to HCV, HIV and HTLV were also screened in all patients by commercially available assays. Serum aminotransferase (AST, ALT) levels were measured by spectrophotometry. 17 anti-HEV-positive patients were found and prevalence was 4.8%, varying from 1.8 - 9.8% in the various HD units. Prevalence of HBsAg and anti-HCV was 5.7% (2.9 - 15%) and 23.6% (11.5 −36.2%) respectively. The anti-HEV prevalence was increased compared to healthy blood donors in Greece (0.26%, p & 0.01). The highest prevalence of anti-HEV was seen at the HD unit of the General Hospital of Karditsa (9.8%). Risk factors for anti-HEV antibody were not identified: no association was found between anti-HEV positivity and age or sex, duration of HD, hepatitis B or C virus infection markers, previously elevated aminotransferase levels or history of transfusion. Our investigation of HEV infection in the cohort of HD patients in central Greece showed that the prevalence of anti-HEV was greater than in healthy blood donors. There was no association to blood borne infections (HBV, HCV). The high prevalence of anti-HEV we found in one HD unit was probably related to a local infection in the past. However, long-term prospective studies are needed in an attempt to identify whether intra-unit factors are also responsible for the increased prevalence of serologic markers of HEV infection among HD patients." @default.
• W5555583 created "2016-06-24" @default.
• W5555583 creator A5009238813 @default.
• W5555583 creator A5013437604 @default.
• W5555583 creator A5014047569 @default.
• W5555583 creator A5016234007 @default.
• W5555583 creator A5037325404 @default.
• W5555583 creator A5047507072 @default.
• W5555583 creator A5056158677 @default.
• W5555583 creator A5065018889 @default.
• W5555583 creator A5070460928 @default.
• W5555583 creator A5078533359 @default.
• W5555583 creator A5081183150 @default.
• W5555583 date "2004-10-01" @default.
• W5555583 modified "2023-10-06" @default.
• W5555583 title "Hepatitis E Virus Antibodies in Hemodialysis Patients: An Epidemiological Survey in Central Greece" @default.
• W5555583 cites W1966014499 @default.
• W5555583 cites W1966385054 @default.
• W5555583 cites W1975333036 @default.
• W5555583 cites W1978536776 @default.
• W5555583 cites W1991323177 @default.
• W5555583 cites W1998553908 @default.
• W5555583 cites W2000276642 @default.
• W5555583 cites W2033339262 @default.
• W5555583 cites W2045944379 @default.
• W5555583 cites W2064483480 @default.
• W5555583 cites W2065609948 @default.
• W5555583 cites W2073448745 @default.
• W5555583 cites W2085903644 @default.
• W5555583 cites W2090505030 @default.
• W5555583 cites W2093027388 @default.
• W5555583 cites W2098723237 @default.
• W5555583 cites W2123371314 @default.
• W5555583 cites W2124464728 @default.
• W5555583 cites W2125067198 @default.
• W5555583 cites W2148513755 @default.
• W5555583 cites W2167745211 @default.
• W5555583 cites W2171970490 @default.
• W5555583 cites W4256456645 @default.
• W5555583 doi "https://doi.org/10.1177/039139880402701005" @default.
• W5555583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15560678" @default.
• W5555583 hasPublicationYear "2004" @default.
• W5555583 type Work @default.
• W5555583 sameAs 5555583 @default.
• W5555583 citedByCount "47" @default.
• W5555583 countsByYear W55555832012 @default.
• W5555583 countsByYear W55555832013 @default.
• W5555583 countsByYear W55555832014 @default.
• W5555583 countsByYear W55555832015 @default.
• W5555583 countsByYear W55555832016 @default.
• W5555583 countsByYear W55555832017 @default.
• W5555583 countsByYear W55555832018 @default.
• W5555583 countsByYear W55555832019 @default.
• W5555583 countsByYear W55555832020 @default.
• W5555583 countsByYear W55555832023 @default.
• W5555583 crossrefType "journal-article" @default.
• W5555583 hasAuthorship W5555583A5009238813 @default.
• W5555583 hasAuthorship W5555583A5013437604 @default.
• W5555583 hasAuthorship W5555583A5014047569 @default.
• W5555583 hasAuthorship W5555583A5016234007 @default.
• W5555583 hasAuthorship W5555583A5037325404 @default.
• W5555583 hasAuthorship W5555583A5047507072 @default.
• W5555583 hasAuthorship W5555583A5056158677 @default.
• W5555583 hasAuthorship W5555583A5065018889 @default.
• W5555583 hasAuthorship W5555583A5070460928 @default.
• W5555583 hasAuthorship W5555583A5078533359 @default.
• W5555583 hasAuthorship W5555583A5081183150 @default.
• W5555583 hasConcept C104317684 @default.
• W5555583 hasConcept C107130276 @default.
• W5555583 hasConcept C119599485 @default.
• W5555583 hasConcept C126322002 @default.
• W5555583 hasConcept C127413603 @default.
• W5555583 hasConcept C135763542 @default.
• W5555583 hasConcept C159047783 @default.
• W5555583 hasConcept C159654299 @default.
• W5555583 hasConcept C203014093 @default.
• W5555583 hasConcept C2522874641 @default.
• W5555583 hasConcept C2776029263 @default.
• W5555583 hasConcept C2777410769 @default.
• W5555583 hasConcept C2778063415 @default.
• W5555583 hasConcept C2780593183 @default.
• W5555583 hasConcept C2780777367 @default.
• W5555583 hasConcept C2781096931 @default.
• W5555583 hasConcept C55493867 @default.
• W5555583 hasConcept C71924100 @default.
• W5555583 hasConcept C761482 @default.
• W5555583 hasConcept C86803240 @default.
• W5555583 hasConcept C90924648 @default.
• W5555583 hasConceptScore W5555583C104317684 @default.
• W5555583 hasConceptScore W5555583C107130276 @default.
• W5555583 hasConceptScore W5555583C119599485 @default.
• W5555583 hasConceptScore W5555583C126322002 @default.
• W5555583 hasConceptScore W5555583C127413603 @default.
• W5555583 hasConceptScore W5555583C135763542 @default.
• W5555583 hasConceptScore W5555583C159047783 @default.
• W5555583 hasConceptScore W5555583C159654299 @default.
• W5555583 hasConceptScore W5555583C203014093 @default.
• W5555583 hasConceptScore W5555583C2522874641 @default.

• next